LuvAminos
ProductsResearchAffiliate ProgramContact us
Luvaminos

Research-grade peptides for laboratory and in-vitro research. Third-party tested, documented per batch.

(505) 460-8488

[email protected]

Shop

  • All Products

Resources

  • Research Library
  • Certificates of Analysis
  • Affiliate Program
  • Loyalty Program
  • Refer a Friend

Support

  • Contact Us
  • FAQ
  • Shipping Info
  • Returns & Refunds

Legal

  • Privacy Policy
  • Your Privacy Choices
  • Terms of Service
  • Affiliate Terms
  • Disclaimer
  • Research Use Only

!FDA Disclaimer — Research Use Only

Statements regarding these products have not been evaluated by the U.S. Food and Drug Administration. These products are intended for laboratory and in-vitro research use only and are not for human or veterinary consumption of any kind. They are not drugs, foods, or supplements, are not FDA approved, and are not intended to diagnose, treat, cure, or prevent any disease. All products are sold exclusively to qualified researchers and must be handled by trained professionals. Read the full disclaimer →

© 2026 Luvaminos LLC. All products for research purposes only. Not for human consumption. Not FDA approved.

1209 Mountain Road PL NE STE R, Albuquerque, NM 87110

  • VisaVISA
  • Mastercard
  • American ExpressAMEX
  • DiscoverDiscover
  • Ethereum
  • SSL Secured
  • 99%+ Purity
  • Shipment Protection
Research/Tirzepatide

Metabolic

Tirzepatide

A dual-receptor agonist examined in preclinical metabolic research.

Molecular Profile

Type

Synthetic peptide (acylated, 39 residues)

Molecular formula

C225H348N48O68

Molecular weight

~4,814 g/mol

CAS number

2023788-19-2

Amino acids

39

Fatty acid chain

C20 diacid

Modification

Aib at positions 2 and 13; C-terminal amide; Lys20 C20 fatty-diacid acylation via gamma-Glu and two AEEA linkers.

Mechanism & Target Class

A GIP-sequence-based single peptide that activates two class B GPCRs - the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R), with GIPR-biased potency. Aib residues confer protease resistance; the C20-diacid side chain provides albumin binding.

Research Focus

Used as a reference dual GIP/GLP-1R agonist in receptor-binding and preclinical metabolic research.

Storage & Handling

Lyophilized

-20°C (-80°C long term)

powder typically stable ~24 months.

Reconstituted

-20°C ~1 month

2-8°C for short-term use only.

Aliquot to avoid freeze-thaw; protect from light; keep sealed and dry.

References

  1. 1

    Coskun T, et al. (2018). Mol Metab

    DOI: 10.1016/j.molmet.2018.09.009
  2. 2

    Nauck MA, D'Alessio DA (2022). Cardiovasc Diabetol

    DOI: 10.1186/s12933-022-01604-7

Primary Database

PubChem CID 156588324↗

Research Use Only

These products are intended for research purposes only and are not for human consumption. Not FDA approved. Not intended to diagnose, treat, cure, or prevent any disease.